Regional differences in perivascular adipose tissue impacting vascular homeostasis

Trends in Endocrinology and Metabolism

Volumn 26, Issue 7, 2015, Pages 367-375

  Gil Ortega, Marta ^a   Somoza, Beatriz ^a   Huang, Yu ^b   Gollasch, Maik ^c   Fernández Alfonso, Maria S ^d  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d INSTITUTO PLURIDISCIPLINAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; BLOOD VESSEL WALL; CELL DIFFERENTIATION; CELL GROWTH; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULARIZATION; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; HOMEOSTASIS; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84937515092     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.04.003     Document Type: Review

References (79)

1. Vanhoutte P.M., Mombouli J.V. Vascular endothelium: vasoactive mediators. Prog. Cardiovasc. Dis. 1996, 39:229-238.
2. Hill C.E., et al. Heterogeneous control of blood flow amongst different vascular beds. Med. Res. Rev. 2001, 21:1-60.
3. Amis E.S., Cronan J.J. The renal sinus: an imaging review and proposed nomenclature for sinus cysts. J. Urol. 1988, 139:1151-1159.
4. Iacobellis G. Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 2014, 46:8-15.
5. Britton K.A., et al. Prevalence, distribution, and risk factor correlates of high thoracic periaortic fat in the Framingham Heart Study. J. Am. Heart Assoc. 2012, 1:e004200.
6. Chughtai H.L., et al. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 2010, 56:901-906.
7. Dreifaldt M., et al. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting. Ann. Thorac. Surg. 2013, 96:105-111.
8. Fitzgibbons T.P., Czech M.P. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J. Am. Heart Assoc. 2014, 3:e000582.
9. Fox C.S., et al. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circ. Cardiovasc. Imaging 2010, 3:515-519.
10. Lehman S.J., et al. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010, 210:656-661.
11. Malinowski M., et al. Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. Eur. J. Cardiothorac. Surg. 2008, 33:225-231.
12. Owen M.K., et al. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013, 128:9-18.
13. Ozen G., et al. Control of human vascular tone by prostanoids derived from perivascular adipose tissue. Prostaglandins Other Lipid Mediat. 2013, 107:13-17.
14. Rittig K., et al. Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 2008, 51:2093-2099.
15. Shields K.J., et al. Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. Atherosclerosis 2013, 231:129-135.
16. Souza D.S., et al. No-touch" technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass grafting maintains an intact endothelium. Scand. Cardiovasc. J. 1999, 33:323-329.
17. Wagner R., et al. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 2012, 55:2054-2058.
18. Ahmed S.R., et al. Human saphenous vein and coronary bypass surgery: ultrastructural aspects of conventional and "no-touch" vein graft preparations. Histol. Histopathol. 2004, 19:421-433.
19. Chatterjee T.K., et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ. Res. 2009, 104:541-549.
20. Dreifaldt M., et al. The vasa vasorum and associated endothelial nitric oxide synthase is more important for saphenous vein than arterial bypass grafts. Angiology 2013, 64:293-299.
21. Poissonnet C.M., et al. The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum. Dev. 1984, 10:1-11.
22. Gesta S., et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6676-6681.
23. Tchkonia T., et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013, 17:644-656.
24. Omar A., et al. Proinflammatory phenotype of perivascular adipocytes. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1631-1636.
25. Mauro C.R., et al. Attenuated adiposopathy in perivascular adipose tissue compared with subcutaneous human adipose tissue. Am. J. Surg. 2013, 206:241-244.
26. Ghosh A.K., Vaughan D.E. PAI-1 in tissue fibrosis. J. Cell Physiol. 2012, 227:493-507.
27. Matthias A., et al. Characterization of perfused periaortic brown adipose tissue from the rat. Can. J. Physiol. Pharmacol. 1994, 72:344-352.
28. Kortelainen M.L., et al. Immunohistochemical detection of human brown adipose tissue uncoupling protein in an autopsy series. J. Histochem. Cytochem. 1993, 41:759-764.
29. Galvez-Prieto B., et al. Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J. Endocrinol. 2008, 197:55-64.
30. Fitzgibbons T.P., et al. Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1425-H1437.
31. Padilla J., et al. Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304:R543-R552.
32. Police S.B., et al. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1458-1464.
33. Chang L., et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 2012, 126:1067-1078.
34. Watts S.W., et al. Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1236-H1247.
35. Lohn M., et al. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002, 16:1057-1063.
36. Fesus G., et al. Adiponectin is a novel humoral vasodilator. Cardiovasc. Res. 2007, 75:719-727.
37. Galvez B., et al. Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1297-1302.
38. Verlohren S., et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004, 44:271-276.
39. Schleifenbaum J., et al. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J. Hypertens. 2010, 28:1875-1882.
40. Zavaritskaya O., et al. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction. Hypertension 2013, 61:151-159.
41. Galvez-Prieto B., et al. A reduction in the amount and anti-contractile effect of periadventitial mesenteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens. Res. 2008, 31:1415-1423.
42. Gollasch M. Vasodilator signals from perivascular adipose tissue. Br. J. Pharmacol. 2012, 165:633-642.
43. 2S in periadventitial vasoregulation of rat and mouse aortas. PLoS ONE 2012, 7:e41951.
44. Fang L., et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J. Hypertens. 2009, 27:2174-2185.
45. Lee Y.C., et al. Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 2011, 124:1160-1171.
46. Ca channels to induce anticontractile responses. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H786-H795.
47. Ca channels and adiponectin. Br. J. Pharmacol. 2013, 169:1500-1509.
48. Gao Y.J., et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J. Thorac. Cardiovasc. Surg. 2005, 130:1130-1136.
49. Gao Y.J., et al. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br. J. Pharmacol. 2007, 151:323-331.
50. Lee R.M., et al. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J. Hypertens. 2009, 27:782-790.
51. Lee R.M., et al. Mas receptors in modulating relaxation induced by perivascular adipose tissue. Life Sci. 2011, 89:467-472.
52. Dashwood M.R., et al. Perivascular fat-derived leptin: a potential role in improved vein graft performance in coronary artery bypass surgery. Interact. Cardiovasc. Thorac. Surg. 2011, 12:170-173.
53. Dashwood M.R., et al. Re: Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. Eur. J. Cardiothorac. Surg. 2008, 33:1161-1162. author reply 1162-1163.
54. Gil-Ortega M., et al. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat diet-derived endothelial dysfunction. PLoS ONE 2014, 9:e95312.
55. Payne G.A., et al. Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-β pathway. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1711-1717.
56. Schroeter M.R., et al. Leptin-dependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation. Arterioscler. Thromb. Vasc. Biol. 2013, 33:980-987.
57. Lu C., et al. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur. J. Pharmacol. 2010, 634:107-112.
58. -/- mice. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H667-H675.
59. Henrichot E., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2594-2599.
60. Mazurek T., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
61. Baker A.R., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol. 2006, 5:1.
62. Iacobellis G., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
63. Greenstein A.S., et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009, 119:1661-1670.
64. Maenhaut N., et al. Hypoxia enhances the relaxing influence of perivascular adipose tissue in isolated mice aorta. Eur. J. Pharmacol. 2010, 641:207-212.
65. Houben A.J., et al. Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease. Curr. Cardiovasc. Risk Rep. 2012, 6:80-90.
66. Eringa E.C., et al. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007, 14:389-402.
67. Lu C., et al. Alterations in perivascular adipose tissue structure and function in hypertension. Eur. J. Pharmacol. 2011, 656:68-73.
68. Galvez-Prieto B., et al. Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension. Front. Pharmacol. 2012, 3:103.
69. Gao Y.J., et al. Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life. Eur. J. Pharmacol. 2008, 590:264-268.
70. Gao Y.J., et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes. Res. 2005, 13:687-692.
71. Wong W.T., et al. Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metab. 2011, 14:104-115.
72. Gabriely I., et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 2002, 51:2951-2958.
73. Gavrilova O., et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J. Clin. Invest. 2000, 105:271-278.
74. Tran T.T., et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008, 7:410-420.
75. Unami A., et al. Comparison of gene expression profiles between white and brown adipose tissues of rat by microarray analysis. Biochem. Pharmacol. 2004, 67:555-564.
76. Kang J.G., et al. Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. Metabolism 2010, 59:46-53.
77. Walden T.B., et al. Recruited vs. nonrecruited molecular signatures of brown, 'brite' and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E19-E31.
78. Xue B., et al. Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J. Lipid Res. 2007, 48:41-51.
79. Wu J., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.